Business & Finance

Roche Q1 sales down on forex effects

  • Quarterly group revenues came in at 14.72 billion Swiss francs
Published Updated
By

Swiss drugmaker Roche said on Thursday that its first-quarter sales declined because of negative foreign exchange effects but rose at constant exchange rates.

Quarterly group revenues came in at 14.72 billion Swiss francs ($18.74 billion), in line with average analyst expectations of about 14.73 billion francs cited by Visible Alpha.

Read Also